Related references
Note: Only part of the references are listed.Ezh2 promotes mammary tumor initiation through epigenetic regulation of the Wnt and mTORC1 signaling pathways
Linshan Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)
Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo
Sherif Attalla et al.
ONCOGENE (2021)
Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments
Iga K. Mieczkowska et al.
CELL DEATH & DISEASE (2021)
NOTCH and EZH2 collaborate to repress PTEN expression in breast cancer
Kyrie Pappas et al.
COMMUNICATIONS BIOLOGY (2021)
Epigenetic mechanisms in breast cancer therapy and resistance
Liliana Garcia-Martinez et al.
NATURE COMMUNICATIONS (2021)
Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation
Andras Lanczky et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2021)
The interactions of Bcl9/Bcl9L with beta-catenin and Pygopus promote breast cancer growth, invasion, and metastasis
Vida Vafaizadeh et al.
ONCOGENE (2021)
Parsing β-catenin's cell adhesion and Wnt signaling functions in malignant mammary tumor progression
David Buechel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Rheb1-Independent Activation of mTORC1 in Mammary Tumors Occurs through Activating Mutations in mTOR
Bin Xiao et al.
CELL REPORTS (2020)
Dual Regulation of Histone Methylation by mTOR Complexes Controls Glioblastoma Tumor Cell Growth via EZH2 and SAM
Mio Harachi et al.
MOLECULAR CANCER RESEARCH (2020)
E2F7-EZH2 axis regulates PTEN/AKT/mTOR signalling and glioblastoma progression
Rui Yang et al.
BRITISH JOURNAL OF CANCER (2020)
MBD2 and EZH2 regulate the expression of SFRP1 without affecting its methylation status in a colorectal cancer cell line
Jun Yu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)
Long Non-Coding RNA SNHG1 Regulates the Wnt/β-Catenin and PI3K/AKT/mTOR Signaling Pathways via EZH2 to Affect the Proliferation, Apoptosis, and Autophagy of Prostate Cancer Cell
Junyi Chen et al.
FRONTIERS IN ONCOLOGY (2020)
Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities
Xiufang Xu et al.
MOLECULAR CANCER (2020)
Molecular Mechanisms Directing PRC2 Recruitment and H3K27 Methylation
Anne Laugesen et al.
MOLECULAR CELL (2019)
An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis
Harvey W. Smith et al.
NATURE COMMUNICATIONS (2019)
The WNT10B Network Is Associated with Survival and Metastases in Chemoresistant Triple-Negative Breast Cancer
Ikbale El Ayachi et al.
CANCER RESEARCH (2019)
CBX6 is negatively regulated by EZH2 and plays a potential tumor suppressor role in breast cancer
Houliang Deng et al.
SCIENTIFIC REPORTS (2019)
Gene expression signature of atypical breast hyperplasia and regulation by SFRP1
Kelly J. Gregory et al.
BREAST CANCER RESEARCH (2019)
Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program
Alison Hirukawa et al.
NATURE COMMUNICATIONS (2018)
Progressive polarity loss and luminal collapse disrupt tissue organization in carcinoma
Ruba Halaoui et al.
GENES & DEVELOPMENT (2017)
The Multiple Facets of PRC2 Alterations in Cancers
M. Wassef et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
Tumor Heterogeneity in Breast Cancer
Gulisa Turashvili et al.
FRONTIERS IN MEDICINE (2017)
Context-dependent actions of Polycomb repressors in cancer
M. Koppens et al.
ONCOGENE (2016)
Downregulation of Enhancer of Zeste Homolog 2 (EZH2) Is Essential for the Induction of Autophagy and Apoptosis in Colorectal Cancer Cells
Yizhou Yao et al.
GENES (2016)
Maintaining cell identity: PRC2-mediated regulation of transcription and cancer
Itys Comet et al.
NATURE REVIEWS CANCER (2016)
Impaired PRC2 activity promotes transcriptional instability and favors breast tumorigenesis
Michel Wassef et al.
GENES & DEVELOPMENT (2015)
The Methyltransferase EZH2 is not Required for Mammary Cancer Development, Although High EZH2 and Low H3K27me3 Correlate With Poor Prognosis of ER-Positive Breast Cancers
Woo Kyun Bae et al.
MOLECULAR CARCINOGENESIS (2015)
Myeloid WNT7b Mediates the Angiogenic Switch and Metastasis in Breast Cancer
Eun-Jin Yeo et al.
CANCER RESEARCH (2014)
Luminal B Breast Cancer: Molecular Characterization, Clinical Management, and Future Perspectives
Felipe Ades et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
mTORC1 signaling controls multiple steps in ribosome biogenesis
Valentina Iadevaia et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression
Trisha Rao et al.
BREAST CANCER RESEARCH (2014)
Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts
Adam D. Pfefferle et al.
GENOME BIOLOGY (2013)
Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes
Karolina Holm et al.
MOLECULAR ONCOLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
mTOR signaling in disease
Eva Dazert et al.
CURRENT OPINION IN CELL BIOLOGY (2011)
Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers
Shuet Theng Lee et al.
MOLECULAR CELL (2011)
The Polycomb complex PRC2 and its mark in life
Raphael Margueron et al.
NATURE (2011)
Epigenetics in breast cancer: what's new?
Yi Huang et al.
BREAST CANCER RESEARCH (2011)
Molecular mechanisms of mTOR-mediated translational control
Xiaoju Max Ma et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
ShcA signalling is essential for tumour progression in mouse models of human breast cancer
Josie Ursini-Siegel et al.
EMBO JOURNAL (2008)
EZH1 Mediates Methylation on Histone H3 Lysine 27 and Complements EZH2 in Maintaining Stem Cell Identity and Executing Pluripotency
Xiaohua Shen et al.
MOLECULAR CELL (2008)
Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases
C. Mayer et al.
ONCOGENE (2006)
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
IM Bachmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Regulation of cap-dependent translation by eIF4E inhibitory proteins
JD Richter et al.
NATURE (2005)
Wnt proteins in mammary development and cancer
KR Brennan et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2004)
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Role of histone H3 lysine 27 methylation in polycomb-group silencing
R Cao et al.
SCIENCE (2002)
Distinct modes of signal recognition particle interaction with the ribosome
MR Pool et al.
SCIENCE (2002)
A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology
EJ Gunther et al.
FASEB JOURNAL (2002)
Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression
J Hutchinson et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Share Paper
